Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-276-9 | CAS number: 114959-46-5
Endpoint summary
Administrative data
Description of key information
GLP study reporting an oral NOAEL of 100 mg/kg/day in the rat (OECD 408, read-across substance, data considered applicable by ECHA).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 100 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
While the key data is for a read-across substance, it is considered to be applicable to the registration substance (by ECHA) and accepted as valid. The 90d study is the longest exposure duration and provides the best indicator of the effects (subtle or more significant).
Based on the results of the key study (oral administration of EXP1503090 to Crl:CD(SD) rats at dosage levels of 30, 100, and 300 mg/kg/day for a minimum of 90 consecutive days) an oral NOAEL of 100 mg/kg/day in the rat was established. There were reduced body weights in males (up to 13.9% lower) with corresponding lower food consumption, in the 300 mg/kg/day group. This large drop in bodyweight did not recover after testing (recovery group) and there were secondary toxicity effects noted elsewhere in the animals which resulted from this. Hence the bodyweight effects were considered to be adverse and were the basis for the NOAEL. All other test article-related effects were either adaptive in nature or tended to reverse following the cessation of exposure. THe NOAEL in females was 300mg/kg bw/day.
This NOAEL is further supported by the 28d toxicity study in the registration substance, as well as the OECD 421 reproductive toxicity screening study in the registration substance, and finally the developmental toxicity study (414) in the read-across substance; all of these provide a similar effects and dose profile and support the NOAEL for systemic toxicity on repeated exposure as 100mg/kg bw/day.
Justification for classification or non-classification
The NOAEL established for repeat dose toxicity is 100mg/kg bw/day in males, and this is likely to be conservative (the true NOAEL may be somewhat higher). No adverse effects are recorded for this substance or the read-across surrogate below 300mg/kg.
Therefore the registration substance does not require classification under the terms of Directive 67/548/EEC, or CLP or GHS as reflected by Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
